French pharma Onxeo is teaming up with CRO Clinigen to bring blood cancer med belinostat to European patients in dire need through a managed access program.

After raising $31 million just last year, California-based clinical research company Science 37 has now served up a Series C round worth $29 million.

An expert panel has released new guidelines for modern clinical trials, examining the importance of utilizing telehealth technologies in clinical studies.

Medidata is acquiring Mytrus, together with its industry-first electronic informed consent service.

U.K.-based CRO Chiltern has put itself up for sale as it continues the bullish M&A run for contract research groups that has seen a host of deals, JVs and…

China's FDA and Supreme Court, in a seemingly synchronized move, are proposing new actions against forging clinical trial data, and criminal charges are…

Texas-based Moleculin Biotech penned a deal with Theradex Systems to help it run early-stage trials for its candidate annamycin in acute myeloid leukemia.

Accelovance has launched a program focused on advancing early-phase oncology R&D efforts, which the company says haven’t received enough support from the…

Takeda is nearing the final stages of a joint venture with PRA Health Sciences, the product of an expansion of their clinical development partnership in Japan…

CRO